NanoVibronix Inc. (NASDAQ:NAOV) Stock Witnesses Huge Rally: Time to Book Profit?
NanoVibronix Inc. (NASDAQ: NAOV) jumped 248% as investors reacted to the news that The Journal of Medical & Surgical Urology published an article with positive findings of a study that used the company’s UroShield in patients in real-life settings.
The medical devices company is famous for its UroShield and PanShield Surface Acoustic Wave portable Ultrasonic Therapeutic Devices. UroShield was used in 23 patients having reoccurring UTIs. Improvement of subjective and objective measures was recorded weakly, including antibiotic treatment, bladder washout, catheter changes, and blockage, level of pain, mobility, sleep, and nurse or hospitalization visits because of UTIs.
Findings indicated a considerable decrease in antibiotic treatment and number of UTIs, and patients had few catheter changes and blockages with pain-reducing considerably at the end of the study. In addition, the company has submitted the peer-reviewed publication to the National Institute for Clinical Excellence as additional clinical evidence supporting Uroshield for NICE Guidance. So, in the coming weeks, NAOV is a stock to watch.
Market Reaction:
On Friday, NAOV stock soared 248% at $2.61 with more than 115 million shares, compared to its average volume of 2.44 million shares. The stock has moved within a range of $0.7100 – 2.6400 after opening the trade at $0.73. Over the past 52-week, the stock has been trading within a range of $0.5350 – 2.7200.
